Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05805384 · ClinicalTrials.gov registry record · NA
Evaluating a Noise Reduction Algorithm With Cochlear Implant Users
A NA study of Hearing Impairment, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05805384: Recruiting NA study of Hearing Impairment, sponsored by NYU Langone Health.
NCT05805384 is a NA study of Hearing Impairment that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05805384, a NA study of Hearing Impairment, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, a noise reduction algorithm will be implemented in various listening situations to evaluate its effectiveness in improving speech understanding for cochlear implant users ages 12 and older.
Primary Outcome
Participants will listen to sentences and repeat all the words they heard. This outcome measures the percent of words correctly recognized in noisy listening conditions while using the SEDA Noise Reduction (NR) algorithm.
Conditions Studied
Interventions
- DEVICE SEDA
Study Locations (1)
New York
- Tisch Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What NCT05805384 shows while recruiting
NCT05805384 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Hearing Impairment appearing as the primary indexed condition, and to 1 intervention - of which SEDA is the first listed.
NCT05805384 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05805384 about?
NCT05805384 is a clinical study titled "Evaluating a Noise Reduction Algorithm With Cochlear Implant Users". In this study, a noise reduction algorithm will be implemented in various listening situations to evaluate its effectiveness in improving speech understanding for cochlear implant users ages 12 and older.
What is the current status of trial NCT05805384?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-03-01. Estimated completion is 2027-03-01.
What conditions does trial NCT05805384 study?
This clinical trial studies the following conditions: Hearing Impairment.
What interventions are being tested in trial NCT05805384?
The interventions under investigation include: SEDA (DEVICE).
Who is sponsoring clinical trial NCT05805384?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05805384 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05805384's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI